skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Radiation retinopathy after external-beam irradiation: Analysis of time-dose factors

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
; ;  [1]
  1. Univ. of Florida College of Medicine, Gainesville, FL (United States); and others

To investigate the risk of radiation-induced retinopathy according to total radiation dose and fraction size, based on both retorspective and prospectively collected data. Between October 1964 and May 1989, 68 retinae in 64 patients received fractionated external-beam irradiation during the treatment of primary extracranial head and neck tumors. All patients had a minimum of 3 years of ophthalmologic follow-up (range, 3 to 26 years; mean, 9 years; median, 8 years). Twenty-seven eyes in 26 patients developed radiation retinopathy resulting in visual acuity of 20/200 or worse. The mean and median times to the onset of symptoms attributable to retinal ischemia were 2.8 and 2.5 years, respectively. Fourteen of the injured eyes developed rubeosis iridis and/or neovascular glaucoma. Radiation retinopathy was not observed at doses below 45 Gy, but increased steadily in incidence at doses {ge}45Gy. In the range of doses between 45 and 55 Gy, there was an increased risk of injury among patients who received doses per fraction of {ge}1.9Gy (p - .09). There was also a trend toward increased risk of injury among patients who received chemotherapy (two of two vs. four of ten in the 45-51 Gy range; p - .23). The lowest dose associated with retinopathy was 45 Gy delivered to a diabetic patient by twice-a-day fractionation. The data did not suggest an increased risk of radiation retinopathy with increasing age. The current study suggests the importance of total dose as well as dose per fraction, and adds support to a small body of literature suggesting that patients with diabetes mellitus or who receive chemotherapy are at increased risk of injury. A sigmoid dose-response curve is constructed from our current data and data from the literature. 36 refs., 5 figs., 4 tabs.

Sponsoring Organization:
USDOE
OSTI ID:
96057
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Vol. 30, Issue 4; Other Information: PBD: 15 Nov 1994
Country of Publication:
United States
Language:
English

Similar Records

Risk of Radiation Retinopathy in Patients With Orbital and Ocular Lymphoma
Journal Article · Sat Dec 01 00:00:00 EST 2012 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:96057

Preventing radiation retinopathy with hyperfractionation
Journal Article · Tue Mar 01 00:00:00 EST 2005 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:96057

Severe dry-eye syndrome following external beam irradiation
Journal Article · Tue Nov 15 00:00:00 EST 1994 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:96057